| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 216.56 M USD | 182.00 M USD | 183.76 M USD | 138.54 M USD | 160.51 M USD | 150.49 M USD | 124.46 M USD | 118.70 M USD | 110.62 M USD | 107.61 M USD | 103.83 M USD | 85.35 M USD |
| Depreciation & Amortization | 45.69 M USD | 47.97 M USD | 54.94 M USD | 51.85 M USD | 48.88 M USD | 51.28 M USD | 45.86 M USD | 44.67 M USD | 44.38 M USD | 46.20 M USD | 39.96 M USD | 30.52 M USD |
| Stock-Based Compensation | 18.06 M USD | 16.68 M USD | 16.05 M USD | 13.22 M USD | 10.80 M USD | 8.30 M USD | 7.60 M USD | 6.41 M USD | 6.26 M USD | 7.02 M USD | 6.83 M USD | 4.56 M USD |
| Capital Expenditures | — | — | — | 49.09 M USD | 36.14 M USD | 32.08 M USD | 25.79 M USD | 19.17 M USD | 27.53 M USD | 23.03 M USD | 41.30 M USD | 13.20 M USD |
| Cash Flow from Investing | -43.89 M USD | -59.74 M USD | -34.81 M USD | -416.01 M USD | -35.30 M USD | -34.59 M USD | -156.22 M USD | -31.99 M USD | -42.70 M USD | -133.59 M USD | -42.28 M USD | -504.42 M USD |
| Cash Flow from Financing | -152.81 M USD | -133.81 M USD | -153.32 M USD | 246.68 M USD | -102.18 M USD | -101.16 M USD | 43.38 M USD | -71.45 M USD | -68.63 M USD | -19.45 M USD | -25.84 M USD | 261.67 M USD |
| Dividends Paid | 28.29 M USD | 25.58 M USD | 22.87 M USD | 20.71 M USD | 18.72 M USD | 16.70 M USD | 15.13 M USD | 13.43 M USD | 12.07 M USD | 10.72 M USD | 9.25 M USD | 7.86 M USD |
| Stock Buybacks | 107.64 M USD | 5.68 M USD | 4.47 M USD | 35.42 M USD | 35.24 M USD | 13.46 M USD | 21.32 M USD | 1.39 M USD | 1.91 M USD | 1.59 M USD | 1.21 M USD | 1.07 M USD |
| Free Cash Flow | — | — | — | 89.45 M USD | 124.37 M USD | 118.41 M USD | 98.67 M USD | 99.53 M USD | 83.09 M USD | 84.58 M USD | 62.53 M USD | 72.15 M USD |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for diverse industries worldwide. Operating through three key segments, it leads in Human Nutrition and Health, providing human-grade choline nutrients, mineral amino acid chelated products, and ingredients for food, beverage, pharmaceutical, and health applications. The Animal Nutrition and Health segment delivers nutritional solutions derived from microencapsulation and chelation technologies, including essential nutrient choline chloride for animal feed. The Specialty Products segment focuses on repackaging and distributing performance gases and chemicals for medical device sterilization, plant nutrition, and industrial uses. Balchem Corporation serves nutritional, food, pharmaceutical, animal health, and industrial markets, emphasizing innovative solutions that enhance health and performance. Founded in 1967 and headquartered in New Jersey, it plays a vital role in the specialty chemicals sector by supplying high-quality, technology-driven ingredients to support global health, nutrition, and industrial needs.